Yatharth Hospital & Trauma Care Services Limited announced its unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026. The Board of Directors also approved and declared an interim dividend of ₹0.50 per equity share. Additionally, the company approved the “Yatharth Hospital & Trauma Care Services Employees Stock Option Scheme – 2026” and re-appointed its Cost Auditor for the financial year 2026-27.
Financial Highlights for Q1 FY27
Yatharth Hospital & Trauma Care Services Limited (the “Company”) has released its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors considered and approved these results, along with the Limited Review Report issued by M/s. MSKA & Associates LLP.
Interim Dividend Declared
Further to a prior communication, the Board has approved and declared the first interim dividend for the Financial Year 2026-27. The dividend amounts to ₹0.50 per equity share of face value ₹10 each, representing 5% of the face value. The total payout for this interim dividend is approximately ₹4,81,77,178.50. The record date for determining entitlement to this dividend has been fixed as August 14, 2026.
Employee Stock Option Scheme Approved
In line with SEBI regulations, the “Yatharth Hospital & Trauma Care Services Employees Stock Option Scheme – 2026” (ESOP 2026) has been approved by the Board of Directors, subject to shareholder approval. This scheme is formulated by the Company and its subsidiaries, aiming to incentivize employees.
Cost Auditor Re-appointed
The Board also approved the re-appointment of M/s Subodh Kumar & Co. as the Cost Accountants for the financial year 2026-27. The firm’s registration number is 104250.
Meeting Details
The Board meeting commenced at 02:33 PM (IST) and concluded at 03:41 PM (IST) on August 10, 2026.
Financial Performance Overview (Standalone)
For the quarter ended June 30, 2026, the standalone results show Total Income of ₹1,896.38 million and Total Expenses of ₹1,515.53 million. Profit Before Tax stood at ₹380.85 million, with a Tax Expense of ₹99.17 million, resulting in a Profit for the period of ₹281.68 million. Total Comprehensive Income was ₹282.38 million. Earnings per equity share (Basic and Diluted) were ₹2.92.
Financial Performance Overview (Consolidated)
On a consolidated basis, for the quarter ended June 30, 2026, Total Income was ₹3,970.07 million and Total Expenses were ₹3,358.02 million. Profit Before Tax stood at ₹612.05 million, with a Tax Expense of ₹157.82 million, leading to a Profit after tax of ₹454.23 million. Total Comprehensive Income was ₹455.57 million. Earnings per equity share (Basic and Diluted) were ₹4.88.
Acquisition Information
During the current quarter, the Group acquired an under-construction hospital at Gurugram for INR 1,000 Million. This facility, with a capacity of 250 beds, is expected to commence commercial operations within the next twelve months.
Source: BSE
